CIK 0001710072 · Large accelerated filer
Edgewise Therapeutics, Inc.
Sign in to watch- Ticker
- EWTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 821725586
- Phone
- 720-262-7002
- Business address
- 1715 38TH ST, BOULDER, CO, 80301
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $201,787
- in 1 filing
Net −$201,787. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-08-12 | MOORE JOHN R General Counsel | Grant or award · Restricted Stock Units | +26,875 | 26,875 | ||
| 2025-08-12 | MOORE JOHN R General Counsel | Grant or award · Stock Option (Right to Buy) | +161,250 | 161,250 | ||
| 2025-08-12 | Derakhshan Behrad Chief Business Officer | Option exercise | +5,781 | 26,136 | ||
| 2025-08-12 | Derakhshan Behrad Chief Business Officer | Sale | −2,491 | $13.39 | $33K | 23,645 |
| 2025-08-12 | Derakhshan Behrad Chief Business Officer | Option exercise · Restricted Stock Units | −5,781 | 17,344 | ||
| 2025-08-12 | Derakhshan Behrad Chief Business Officer | Grant or award · Restricted Stock Units | +30,000 | 30,000 | ||
| 2025-08-12 | Derakhshan Behrad Chief Business Officer | Grant or award · Stock Option (Right to Buy) | +180,000 | 180,000 | ||
| 2025-08-12 | Carruthers R Michael Chief Financial Officer | Option exercise | +5,781 | 87,590 | ||
| 2025-08-12 | Carruthers R Michael Chief Financial Officer | Sale | −1,428 | $13.39 | $19K | 86,162 |
| 2025-08-12 | Carruthers R Michael Chief Financial Officer | Option exercise · Restricted Stock Units | −5,781 | 17,344 | ||
| 2025-08-12 | Carruthers R Michael Chief Financial Officer | Grant or award · Restricted Stock Units | +26,875 | 26,875 | ||
| 2025-08-12 | Carruthers R Michael Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +161,250 | 161,250 | ||
| 2025-08-12 | Russell Alan J Chief Scientific Officer | Option exercise | +5,781 | 25,307 | ||
| 2025-08-12 | Russell Alan J Chief Scientific Officer | Sale | −1,907 | $13.39 | $26K | 23,400 |
| 2025-08-12 | Russell Alan J Chief Scientific Officer | Option exercise · Restricted Stock Units | −5,781 | 17,344 | ||
| 2025-08-12 | Russell Alan J Chief Scientific Officer | Grant or award · Restricted Stock Units | +28,125 | 28,125 | ||
| 2025-08-12 | Russell Alan J Chief Scientific Officer | Grant or award · Stock Option (Right to Buy) | +168,750 | 168,750 | ||
| 2025-08-12 | KOCH KEVIN President and CEO | Option exercise | +17,968 | 38,587 | ||
| 2025-08-12 | KOCH KEVIN President and CEO | Sale | −7,972 | $13.39 | $107K | 30,615 |
| 2025-08-12 | KOCH KEVIN President and CEO | Option exercise · Restricted Stock Units | −17,968 | 53,907 |
Page 7 of 26 · 509 trades